The ability of polyethylene glycol conjugated bovine hemoglobin (PEG-Hb) to adequately deliver oxygen in both exchange transfusion and top-loaded rat models

Artificial Cells, Blood Substitutes, and Immobilization Biotechnology

Volumn 27, Issue 2, 1999, Pages 93-107

  Conover, Charles D ^a   Linberg, Rita ^a   Shum, Kwok L ^a   Shorr, Robert G L ^a  

^a Enzon Incorporated   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD SUBSTITUTES; HEMODYNAMICS; LIVING SYSTEMS STUDIES; OXYGEN; PHOSPHORESCENCE; PHYSIOLOGICAL MODELS; POLYETHYLENE GLYCOLS; TISSUE;

HEMOGLOBIN BASED OXYGEN CARRIERS (HBOC); PARTIAL EXCHANGE TRANSFUSION;

HEMOGLOBIN;

HEMOGLOBIN DERIVATIVE; MACROGOL; METHEMOGLOBIN; PLASMA SUBSTITUTE; POLYETHYLENE GLYCOL CONJUGATED BOVINE HEMOGLOBIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR EFFECT; CONTROLLED STUDY; DRUG HALF LIFE; EXCHANGE BLOOD TRANSFUSION; FEMALE; HEART RATE; INTRAVENOUS DRUG ADMINISTRATION; MEAN ARTERIAL PRESSURE; NONHUMAN; OXYGEN TISSUE LEVEL; OXYGEN TRANSPORT; PHOSPHORESCENCE; RAT; TELEMETRY; TISSUE OXYGENATION;

ANIMALIA; BOVINAE;

EID: 0033105722     PISSN: 10731199     EISSN: None     Source Type: Journal    
DOI: 10.3109/10731199909117685     Document Type: Article

References (31)

1. Benesch, R., Benesch, R., Renthal, R. and Maeda, N.: Affinity labelling of the polyphosphate binding site of hemoglobin. Biochem. 11:3576-3582 (1972).
2. DeVenuto, F.: Evaluation of human and bovine modified-hemoglobin solution as an oxygen-carrying fluid for blood volume replacement. Biomat. Art. Cels Art. Org. 16:77-83 (1988).
3. Sanders, K., Ackers, G. and Sligar, S.: Engineering and design of blood substitutes. Current Opinion in Structural Biology 6:534-540 (1996).
4. Relihan, M. and Litwin, M.: Effect of stroma-free hemoglobin solution on clearance rate and renal function. Surgery 71(3):395-399 (1972).
5. Feola, M., Simoni, J., Tran, R. and Canizaro, P.: Mechanism of toxicity of hemoglobin solutions. Biomat. Art. Cells Art. Org. 16 (1-3):217-226 (1989).
6. Chang, T.: Blood substitutes based on modified hemoglobin prepared by encapsulation or crosslinking: An overview. Biomat. Artif. Cells & Immob. Biotech. 20(2-4):159-179 (1992).
7. Nucci, M., Shorr, R. and Abuchowski, A.: The therapeutic value of poly(ethylene glycol)-modified proteins. Adv. Drug Del. Rev. 6:133-151 (1993).
8. Conover, C., Linberg, R., Gilbert, C., Shum, K. and Shorr R.: Effect of polyethylene glycol conjugated bovine hemoglobin (PEG-Hb) in both top-load and exchange transfusion rat models. Art. Organs 21:1066-1075 (1997).
9. Conover, C., Gilbert, C., Shum, K. and Shorr, R. : The impact of polyethylene glycol (PEG) conjugation on bovine hemoglobin's circulatory half-life and renal effects in a rabbit top-loaded transfusion model. Art. Organs 21:369-378 (1997).
10. Conover, C., Lejeune, L., Shum, K., Gilbert, C. and Shorr, R.: Physiological effect of polyethylene glycol conjugation on stroma-free bovine hemoglobin in the conscious dog after partial exchange transfusion. Art. Organs 21:369-378 (1997).
11. Conover, C., Malatesta, P., Lejeune, L., Chang, C. and Shorr, R.: The effects of polyethylene glycol conjugated bovine hemoglobin (PEG-Hb) in a conscious porcine model. J Inv. Med. 44:238-246 (1996).
12. Song, D., Olano, M., Wilson, D., Pastusko, A., Tammela, O., Nho, K. and Shorr, R.: Comparison of the efficacy of blood and PEG-hemoglobin in recovery of newborn piglets from hemorrhagic hypotension: Effect on blood pressure, cortical extracellular oxygen and dopamine in the brain. Transfusion 35:552-558 (1995).
13. Nho, K., Zalipsky, S., Abuchowski, A. and Davis, F.: PEG-modified hemoglobin as an effective oxygen carrier. Poly(Ethylene Glycol) Chemistry: Biotechnical and Biomedical Applications. Harris JM. Plenum Press, New-York, 171-182 (1992).
14. Nho, K., Zalipsky, S., and Davis, F.: Chemically modified hemoglobin as an effective, stable, non-immunogenic red blood substitute. U.S. Patent # 5,234,903 (1993).
15. Manning, J.M.: Influence of ligation state and concentration of hemoglobin A on its cross-linking by glycolaldehyde: Functional properties of cross-linked, carboxymethylated hemoglobin. Biochemistry 27:6640-6644 (1988).
16. Rausch, C.W. and Feola, M. Extra pure semi-synthetic blood substitute. U.S.Patent # 5,084,558 (1992).
17. Rumsey, W., Vanderkooi, J. and Wilson, D.: Imaging of phosphorescence: A novel method for measuring oxygen distribution in perfused tissue. Science 241:1649-51 (1988).
18. Wilson, D. and Cerniglia, D.: Localizaton of tumors and evaluation of their state of oxygenation by phosphorescence imaging. Cancer Res. 52:3988-93 (1992).
19. Lumley, J., Green, C., Lear, C. and Angell-James, J.: Eds. Essentials of Experimental Surgery. Boston: Butterworth, (1989).
20. Conover, C., Linberg, R., Lejeune, L., Gilbert, C., Shum, K. and Shorr, R.: Evaluation of the oxygen delivery ability of PEG-Hemoglobin in Sprague-Dawley rats during hemodilution. Art. Cells, Blood Subs., and Immob. Biotech. In press.
21. Anderson, M., Mouritzer, C. and Gabrielli E.: Mechanisms of plasma hemoglobin clearance and selective deposition in the liver and kidney: Serum haptoglobin levels and selective deposition in the liver and kidney. Ann. Surg. 64:905-912 (1966).
22. Hess, J., Macdonald, V., Gomez, C. and Coppes V.: Increased vascular resistance with hemoglobin-based oxygen carriers. Artif. Cells Blood Subst. Immob. Biotech. 22(3): 361-372 (1994).
23. Migita, R., Gonzales, A., Gonzales, M., Vandegriff, K. and Winslow, R.: Blood volume and cardiac index in rats after exchange transfusion with hemoglobin-based oxygen carriers. J. Appl. Physiol. 82:1995-2002 (1997).
24. Kosara, H., Uozumi, M. and Tyuma I.: The interaction between nitrogen oxides and hemoglobin and endothelium-derived relaxing factor. Free Rad. Biol. Med. 7:653-658 (1989).
25. Kim, W. and Greenburg, A.: Hemoglobin mediated vasoactivity in isolated vascular rings. Art. Cells, Blood Subs., and Immob. Biotech. 23(3): 303-309 (1995).
26. Hart, J., Ledvina, M. and Muldoon, S.: Actions of diaspirin cross-linked hemoglobin on isolated rat and dog vessels. J Lab. Clin. Med. 129: 356-363 (1997).
27. Vandegriff, K. and Winslow, R.: A theoretical analysis of oxygen transport: a new strategy for the design of hemoglobin based red cell substitutes. Blood substitutes: Physiological Basis of Efficacy. Winslow et al., Eds. Birkhauser 143-154 (1995).
28. Tsai, A., Kerger, H. and Intaglietta, M. : Microcirculatory consequences of blood substitution with αα-hemoglobin. Blood substitutes: Physiological Basis of Efficacy. Winslow, R.,M., Vandegriff, K.,D., Intaglietta, M. Eds. Birkhauser 155-174 (1995).
29. Alayash, A. : Effects of intra-and intermolecular crosslinking on the free radical reactions of bovine hemoglobins. Free Rad Biol Med 18:295-301 (1995).
30. Rogers, M., Ryan, B., Cashon, R. and Alayash, A. : Effects on polyermization on the oxygen carrying and redox properties of diaspirin cross-linked hemoglobin. Biochem Biophys Acta 38:135-142 (1995).
31. Linberg, R., Conover, C., Shum, K. and Shorr, R.: Hemoglobin based oxygen carriers: How much methemoglobin is too much? Art. Cells, Blood Subs., and Immob. Biotech. In press.